Argentina

After leading a management buyout of Spring Genetics from Benchmark, Hideyoshi Segovia Uno is working hard to help ensure the international tilapia sector – particularly in Latin America (LATAM) – succeeds, in the face of a raft of emerging challenges.

Chilean biotech startup Aquit is developing a preventative treatment against infections in fish that boosts natural immunity, improves survival rates and replaces the need for antibiotics, according to CEO Daniela Allerbon